Murine polyomavirus provides a valuable model for neoplastic transformation. The virus causes a broad spectrum of tumors in animals. This means that leads developed in the laboratory can be readily tested in the host. Studies on polyoma have repeatedly provided insight into basic mechanisms of cellular growth regulation. Tyrosine kinase signaling and phosphatidylinositol 3-kinase (PI3K) signaling are two fundamental mechanisms uncovered from studies on polyoma. Middle T antigen (MT) is the major transforming protein of polyomavirus. It is always necessary, and often sufficient, for cellular transformation by polyoma. This subproject will extend our knowledge of MT and its signaling based on leads developed in the previous project period. There are 4 specific aims. 1) We have shown that MT activates the small GTPase Ral. We will examine how MT activates Ral. We will test the role of Ral in MT transformation. Since Ral functions in trafficking processes including secretion, we will test MT function there. 2) MT induces osteopontin, a secreted protein thought to be linked to transformation and metastasis. We will determine how MT regulates osteopontin. We will determine the role of osteopontin in MT transformation by examining tumor profiles. Using breast cancer and hemangioma models, we will test the role of osteopontin in metastasis and in cell recruitment. We will initiate structural analysis of MT using NMR to determine the structure of the portion of MT that interacts with downstream targets such as Shc and PI3K. We will then map the interaction surface between MT and p85 of PI3K or Shc. Finally, there is strong genetic evidence suggesting that there are undiscovered MT binding proteins. We will use tandem affinity purification and mass spectrometry to identify them. We will determine the MT sequences required for their interaction. We will test their function in MT assays for transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA050661-16
Application #
6989675
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-04-27
Project End
2009-02-28
Budget Start
2004-04-27
Budget End
2005-02-28
Support Year
16
Fiscal Year
2004
Total Cost
$338,459
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Becker, Jürgen C; Stang, Andreas; Hausen, Axel Zur et al. (2018) Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother 67:341-351
Becker, Jürgen C; Stang, Andreas; DeCaprio, James A et al. (2017) Merkel cell carcinoma. Nat Rev Dis Primers 3:17077
Denis, Deborah; Rouleau, Cecile; Schaffhausen, Brian S (2017) A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling. J Virol 91:
Starrett, Gabriel J; Marcelus, Christina; Cantalupo, Paul G et al. (2017) Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma. MBio 8:
Cizmecioglu, Onur; Ni, Jing; Xie, Shaozhen et al. (2016) Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. Elife 5:
Rouleau, Cecile; Pores Fernando, Arun T; Hwang, Justin H et al. (2016) Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP. J Virol 90:7032-7045
Pores Fernando, A T; Andrabi, S; Cizmecioglu, O et al. (2015) Polyoma small T antigen triggers cell death via mitotic catastrophe. Oncogene 34:2483-92
Berrios, Christian; Jung, Joonil; Primi, Blake et al. (2015) Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors. J Virol 89:857-62
Luo, Leo Y; Kim, Eejung; Cheung, Hiu Wing et al. (2015) The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Mol Cancer Res 13:502-9
Hettmer, Simone; Schinzel, Anna C; Tchessalova, Daria et al. (2015) Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. Elife 4:

Showing the most recent 10 out of 147 publications